RELIABLE RESEARCH PARTNER WITH EXPERTISE, KNOW-HOW AND EXPERIENCE IN DRUG DISCOVERY FROM PLANT NATURAL PRODUCTS Read more in a new company teaser 植物天然由来物を用いた創薬における専門知識、 ノウハウ、経験の豊富な信頼できる共同研究パートナー 日本語版はこちらからダウンロードして下さい
“Öffentlich getriebene Impulse zur Unterstützung der Biotechnologie”, M. Lamottke, Y. Zhou, “Das Gesundheitswesen in China” Medizinisch Wissentschaftliche Verlagsgesellschaft, 2017, Pp. 165-179 ISBN: 978-3-95466-303-3 „Das Gesundheitswesen in China“ schildert die systembedingten und kulturellen Hintergründe des Umgangs mit Gesundheit und Krankheit. Es …
Prof. David C. Henshall, Prof. Hajo M. Hamer, MD, Prof. R. Jeroen Pasterkamp, PhD, Prof. David B. Goldstein, PhD, Prof. Jørgen Kjems, PhD, Prof. Jochen H. M. Prehn, PhD, Stephanie Schorge, PhD, Kai Lamottke, PhD, Felix Rosenow, MD, THE LANCET …
C. Dion, C. Haug, H. Guan, C. Ripoll, P. Spiteller, A. Coussaert, E. Boulet, D. Schmidt, J. Wei, Y. Zhou, K. Lamottke, Natural product communications, 10(4), 597-603, April 2015. Inflammation plays a major role in many diseases, for instance in …
S. Helleboid, C. Haug, K. Lamottke, Y. Zhou, J. Wei, S. Daix, L. Cambula, G. Rigou, D. W. Hum, R. Walczak, Journal of Biomolecular Screening, Jul 2013, DOI: 10.1177/1087057113497095. New target validation has always been a challenge for the pharmaceutical …
Bicoll Newsletter Edition 2012: Bicoll as Partner of a € 2.7 M European-Funded EuroTransBio Program Nutraceutical Research Alliance with Naturalpha (France) New Service Platform based on Innovative Fragment Library Concept Ready to Market What to expect from Bicoll in 2012 …
Chemical & Engineering News, 89(7), February 14, 2011 “At Bicoll Biotechnology in Shanghai’s Zhangjiang Hi-Tech Park, Managing Director Kai Lamottke is skeptical that the Chinese drug industry has openings for a sizable contingent of scientists from abroad. “The scientists with …
European Biopharmaceutical Review, January 2011, p.52 Kai Lamottke at Bicoll GmbH, Christophe Ripoll at Naturalpha and Robert Walczak at Genfit SA ask if the biotech industry can afford to turn away from natural product drug discovery research. One of the …
Bicoll Newsletter Edition 2011 Successful joint research project on aurora kinase inhibitors with EMBL (European Molecular Biology Laboratory) Grant from Shanghai Science Technology Committee for Bicoll Biotechnology (Shanghai) Co. Ltd. Enlargement of analytical department and medicinal chemistry team What to …